Clinical/Medical Sciences

1 - 5 of 5 listings
Listings
  • GPC1 ELISA Kit

    GPC1 ELISA Kit

    Clinical/Medical Sciences Shirley (New York ) June 28, 2018 Check with publisher

    Mouse Glypican 1 ELISA Kit kit is a 1.5 hour solid-phase ELISA designed for the quantitative determination of the Glypican 1. This ELISA kit is for research use only, not for therapeutic or diagnostic applications.

  • Webinar On 2018 CPT and HCPCS Updates

    Webinar On 2018 CPT and HCPCS Updates

    Clinical/Medical Sciences Fremont (California) January 16, 2018 Check with publisher

    Training Options Duration: 60 Minutes Tuesday, February 6, 2018 | 10:00 AM PST | 01:00 PM EST Overview: 2018 will see significant changes in each section of the CPT and HCPCS manuals. There have been over 350 code changes with the update. This hour-l...

  • Anti-FUT3 (clone cBR96)-hydrazone-doxorubicin ADC

    Anti-FUT3 (clone cBR96)-hydrazone-doxorubicin ADC

    Clinical/Medical Sciences Shirley (New York) December 18, 2017 Check with publisher

    https://www.creative-biolabs.com/adc/target-fut3-48.htm This ADC product is comprised of an anti-FUT3 monoclonal antibody (clone cBR96) conjugated via a hydrazone linker to adoxorubicin. The doxorubicin is targeted to certain cancers by immunerecogni...

  • Learn Some of the Acceptance Activities in FDA QSR

    Learn Some of the Acceptance Activities in FDA QSR

    Clinical/Medical Sciences Fremont (California) December 8, 2017 Check with publisher

    Overview: This section plays a major role in both purchasing and in production. It is a major contributor to determine whether your supplier and manufacturing process are working effectively. Why should you Attend: As you ensure that your Quality Man...

  • Why Capturing Justifications in Change Control

    Why Capturing Justifications in Change Control

    Clinical/Medical Sciences Fremont (California) December 8, 2017 Check with publisher

    Overview: It is easy to document what process has been performed, what has been investigated or changed or why something is a risk, but the difficult part is knowing how to explain or justify why it should be done or why a product should be released ...